-Advertisement-
-Advertisement-
Home
Post-hoc analysis shows promising results in reducing functional vision loss with avacincaptad pegol
Geographic Atrophy
Post-hoc analysis shows promising results in reducing functional vision loss with avacincaptad pegol
Findings from a post-hoc analysis from the GATHER trials presented at ARVO 2023 signaled that reduced rate of vision loss was correlated with reduced geographic atrophy (GA) growth in patients receiving avacincaptad pegol (ACP). These findings suggest that ACP may be a promising treatment option for patients with GA, regardless...
Read More-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
Videos
22 Feb, 2023
Mark Dlugoss: Patients with geographic atrophy (GA), which is an...
Quizzes
-Advertisement-
-Advertisement-
Stay Connected! Join Our Newsletter
Contact
Grandin Library Building
Six Leigh Street
Clinton, New Jersey 08809
+908-505-8899
[email protected]
© 2023 Ophthalmology 360® is a trademark of International Healthcare Media, LLC. All rights Reserved